Endoscopic Ultrasound-Guided Acquisition of Portal Venous Circulating Tumor Cells as a Potential Diagnostic and Prognostic Tool for Pancreatic Cancer

References

• Moore A, Donahue T. Pancreatic cancer. JAMA. 2019;322(14):1426. doi:10.1001/jama.2019.1469931593274
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.30620402
   PubMed Web of Science ®Google Scholar
• Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921. doi:10.1158/0008-5472.CAN-14-015524840647
   PubMed Web of Science ®Google Scholar
• Mobarki M, Dumollard JM, Dal Col P, Camy F, Peoc’h M, Karpathiou G. Granular cell tumor a study of 42 cases and systemic review of the literature. Pathol Res Pract. 2020;216(4):152865. doi:10.1016/j.prp.2020.15286532089415
   PubMed Web of Science ®Google Scholar
• Luo G, Liu C, Guo M, et al. Potential biomarkers in Lewis negative patients with pancreatic cancer. Ann Surg. 2017;265(4):800–805. doi:10.1097/SLA.000000000000174128267695
   PubMed Web of Science ®Google Scholar
• Zhou B, Xu JW, Cheng YG, et al. Early detection of pancreatic cancer: Where are we now and where are we going? Int J Cancer. 2017;141(2):231–241. doi:10.1002/ijc.3067028240774
   PubMed Web of Science ®Google Scholar
• Pantel K, Speicher MR. The biology of circulating tumor cells. Oncogene. 2016;35(10):1216–1224. doi:10.1038/onc.2015.19226050619
   PubMed Web of Science ®Google Scholar
• Miyamoto DT, Lee RJ, Kalinich M, et al. An RNA-based digital circulating tumor cell Signature is predictive of drug response and early dissemination in prostate cancer. Cancer Discov. 2018;8(3):288–303. doi:10.1158/2159-8290.CD-16-140629301747
   PubMed Web of Science ®Google Scholar
• Guo W, Sun YF, Shen MN, et al. Circulating tumor cells with stem-like phenotypes for diagnosis, prognosis, and therapeutic response evaluation in hepatocellular carcinoma. Clin Cancer Res. 2018;24(9):2203–2213. doi:10.1158/1078-0432.CCR-17-175329374055
   PubMed Web of Science ®Google Scholar
• Deneve E, Riethdorf S, Ramos J, et al. Capture of viable circulating tumor cells in the liver of colorectal cancer patients. Clin Chem. 2013;59(9):1384–1392. doi:10.1373/clinchem.2013.20284623695297
   PubMed Web of Science ®Google Scholar
• Nieto J, Grossbard ML, Kozuch P. Metastatic pancreatic cancer 2008: is the glass less empty? Oncologist. 2008;13(5):562–576. doi:10.1634/theoncologist.2007-018118515741
   PubMed Web of Science ®Google Scholar
• Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol. 2011;192(3):373–382. doi:10.1083/jcb.20101002121300848
   PubMed Web of Science ®Google Scholar
• Buscail E, Chiche L, Laurent C, et al. Tumor-proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells. Mol Oncol. 2019;13(9):1811–1826. doi:10.1002/1878-0261.1253431216108
   PubMed Web of Science ®Google Scholar
• Rahbari NN, Bork U, Kircher A, et al. Compartmental differences of circulating tumor cells in colorectal cancer. Ann Surg Oncol. 2012;19(7):2195–2202. doi:10.1245/s10434-011-2178-122230943
   PubMed Web of Science ®Google Scholar
• Fang ZT, Zhang W, Wang GZ, et al. Circulating tumor cells in the central and peripheral venous compartment - assessing hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma. Onco Targets Ther. 2014;7:1311–1318. doi:10.2147/OTT.S6260525071374
   PubMed Web of Science ®Google Scholar
• Reddy RM, Murlidhar V, Zhao L, et al. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer. J Thorac Cardiovasc Surg. 2016;151(3):852–858. doi:10.1016/j.jtcvs.2015.09.12626614417
   PubMed Web of Science ®Google Scholar
• Tien YW, Kuo HC, Ho BI, et al. A high circulating tumor cell count in portal vein predicts liver metastasis from periampullary or pancreatic cancer: a high portal venous CTC count predicts liver metastases. Medicine. 2016;95(16):e3407. doi:10.1097/MD.000000000000340727100430
   PubMed Web of Science ®Google Scholar
• Chapman CG, Waxman I. EUS-guided portal venous sampling of circulating tumor cells. Curr Gastroenterol Rep. 2019;21(12):68. doi:10.1007/s11894-019-0733-231813055
   PubMedGoogle Scholar
• Catenacci DV, Chapman CG, Xu P, et al. Acquisition of portal venous circulating tumor cells from patients with pancreaticobiliary cancers by endoscopic ultrasound. Gastroenterology. 2015;149(7):1794–1803 e1794. doi:10.1053/j.gastro.2015.08.05026341722
   PubMed Web of Science ®Google Scholar
• Lee JS, Park SS, Lee YK, Norton JA, Jeffrey SS. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA. Mol Oncol. 2019;13(8):1623–1650. doi:10.1002/1878-0261.1253731243883
   PubMed Web of Science ®Google Scholar
• Konigsberg R, Obermayr E, Bises G, et al. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Acta Oncol. 2011;50(5):700–710. doi:10.3109/0284186X.2010.54915121261508
   PubMed Web of Science ®Google Scholar
• Wei T, Zhang X, Zhang Q, et al. Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer. Cancer Lett. 2019;452:237–243. doi:10.1016/j.canlet.2019.03.00930905814
   PubMed Web of Science ®Google Scholar
• Zhao XH, Wang ZR, Chen CL, et al. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: potential role in clinical practice. World J Gastroenterol. 2019;25(1):138–150. doi:10.3748/wjg.v25.i1.13830643364
   PubMed Web of Science ®Google Scholar
• Chapman CG, Ayoub F, Swei E, et al. Endoscopic ultrasound acquired portal venous circulating tumor cells predict progression free survival and overall survival in patients with pancreaticobiliary cancers. Pancreatology. 2020;20(8):1747–1754. doi:10.1016/j.pan.2020.10.03933082106
   PubMed Web of Science ®Google Scholar
• Buscail L. Commentary: pancreatic cancer: is the worst to come? Int J Epidemiol. 2017;46(6):1774–1775. doi:10.1093/ije/dyx14329025067
   PubMed Web of Science ®Google Scholar
• Buscail E, Maulat C, Muscari F, Chiche L, Cordelier P, Dabernat S. Liquid biopsy approach for pancreatic ductal adenocarcinoma. Cancers. 2019;11(6):852. doi:10.3390/cancers11060852
   PubMed Web of Science ®Google Scholar
• Chen J, Ye C, Dong J, et al. Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer. J Transl Med. 2020;18(1):59. doi:10.1186/s12967-020-02237-832028979
   PubMed Web of Science ®Google Scholar
• de Kruijff IE, Sieuwerts AM, Onstenk W, et al. Circulating tumor cell enumeration and characterization in metastatic castration-resistant prostate cancer patients treated with Cabazitaxel. Cancers. 2019;11(8):1212. doi:10.3390/cancers11081212
   PubMed Web of Science ®Google Scholar
• Cohen SJ, Punt CJ, Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26:3213–3221.18591556
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhu Y, Zhang Z, Zhang C, Huang X, Yuan Z. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization. J Exp Clin Cancer Res. 2016;35(1):66. doi:10.1186/s13046-016-0340-027066900
   PubMed Web of Science ®Google Scholar
• Chapman CG, Waxman I. Portal-vein blood samples as a new diagnostic entity for pancreatic cancer. Expert Rev Gastroenterol Hepatol. 2016;10(6):665–667. doi:10.1080/17474124.2016.117691127077275
   PubMed Web of Science ®Google Scholar
• White MG, Lee A, Vicente D, et al. Measurement of portal vein blood circulating tumor cells is safe and may correlate with outcomes in resected pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2021;28(8):4615–4622. doi:10.1245/s10434-020-09518-y33415562
   PubMed Web of Science ®Google Scholar
• Dong X, Ma Y, Zhao X, et al. Spatial heterogeneity in epithelial to mesenchymal transition properties of circulating tumor cells associated with distant recurrence in pancreatic cancer patients. Ann Transl Med. 2020;8(11):676. doi:10.21037/atm-20-78232617296
   PubMed Web of Science ®Google Scholar
• Gall TM, Jacob J, Frampton AE, et al. Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer. JAMA Surg. 2014;149(5):482–485. doi:10.1001/jamasurg.2013.364324599353
   PubMed Web of Science ®Google Scholar
• Liu X, Li C, Li J, et al. Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer. J Cancer. 2018;9(11):2038–2045. doi:10.7150/jca.2398929896289
   PubMed Web of Science ®Google Scholar
• Bidard FC, Huguet F, Louvet C, et al. Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol. 2013;24(8):2057–2061. doi:10.1093/annonc/mdt17623676420
   PubMed Web of Science ®Google Scholar
• Okubo K, Uenosono Y, Arigami T, et al. Clinical impact of circulating tumor cells and therapy response in pancreatic cancer. Eur J Surg Oncol. 2017;43:1050–1055.28233633
   PubMed Web of Science ®Google Scholar